Author

Jianying Chang

Observed names: Chang J, Jian-Ying Chang

Institution: Guiyang Medical University

Observed institutions: Central South University, Guiyang Medical University, China University of Mining and Technology, Guizhou Cancer Hospital, Affiliated Hospital of Guizhou Medical University, Xiangya Hospital Central South University

OpenAlex ID: A5113008407

Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer

2021 · Yong-Xia Li, Jian-Ying Chang, et al. · Journal of Oncology · 57

Lightweight FaceNet Based on MobileNet

2020 · Xinzheng Xu, Meng Du, et al. · International Journal of Intelligence Science · 21

A Comparison of Different Schemes of Neoadjuvant Chemotherapy Followed by Concurrent Chemotherapy and Radiotherapy for Locally Advanced Cervical Cancer: A Retrospective Study

2021 · Xue Tian, Feiyue Yang, et al. · Cancer Management and Research · 17

MPEG-PCL Nanomicelles Platform for Synergistic Metformin and Chrysin Delivery to Breast Cancer in Mice

2021 · Daiqin Luo, Xinjun Wang, et al. · Anti-Cancer Agents in Medicinal Chemistry · 14

Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer

2019 · Fenghu Li, Bi Wang, et al. · Medicine · 8

[Serum level of chemerin and bone mineral density in patients with Graves disease].

2017 · Yu Li, Jianying Chang, et al. · PubMed · 3

Image Style Transfering Based on StarGAN and Class Encoder

2022 · Xinzheng Xu, Jianying Chang, et al. · International Journal of Software and Informatics · 2

A new perspective of different schemes of neoadjuvant chemotherapy followed by concurrent chemotherapy and radiotherapy for locally advanced cervical cancer.

2020 · Xue Tian, Fenghu Li, et al. · Journal of Clinical Oncology · 1

Artesunate Targets MBL2 to Modulate the TLR4/NRF2/HO‑1 Axis and Ameliorate Podophyllotoxin‑Induced Liver Injury

2026 · Wei M, He J, et al. · DOAJ (DOAJ: Directory of Open Access Journals)

Disitamab vedotin for HER2-positive breast cancer with liver metastases: phase 3 results from the RC48-C006 phase 2/3 trial

2026 · Jiayu Wang, Quchang Ouyang, et al. · Nature Communications

Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancer

2025 · Yongxia Li, Yong Li, et al. · Frontiers in Oncology

Efficacy and safety of disitamab vedotin (RC48) in HER2-expressing breast cancer: A multicenter retrospective study.

2024 · Can Yang, Jianying Chang, et al. · Journal of Clinical Oncology

Efficacy and safety of pyrotinib for patients with HER2-positive advanced breast cancer : a retrospective multicenter real-world study

2023 · Yongxia Li, Yong Li, et al. · Research Square

Sarcopenia in postmenopausal women

2019 · Jianying Chang, Huang Bei, et al.

左側qia血門脈子宮内膜腺癌1例。【Powered by NICT】

2015 · Fenghu Li, Ran Li, et al.

Dosimetry of different techniques in postmastectomy radiation therapy on the ipsilateral lung

2011 · Hong Wei, Li Ran, et al. · Zhonghua fangshe yixue yu fanghu zazhi

Works count: 16

Citation count: 123

H-index: 5

I10-index: 4